Publications by authors named "Adher AlSayed"

Claim this Profile
M
Management of Early and Metastatic Breast Cancer: A Consensus Statement from Oncologists in Saudi Arabia.
Sabah Alaklabi, Sadal Al Refaei, Omalkhair Abualkhair, Atlal Abusanad, Saad Akhtar, Adher Alsayed

Oncol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer.
Bader Alshamsan, Mahmoud A Elshenawy, Mohamed Aseafan, Nermin Fahmy, Ahmed Badran, Adher Alsayed

Oncol Lett· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancer.
Hazem Ghebeh, Mahmoud A Elshenawy, Adher D AlSayed, Taher Al-Tweigeri

Immunotherapy· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia.
Bader Alshamsan, Kausar Suleman, Naela Agha, Marwa I Abdelgawad, Mashari J Alzahrani, Adher Alsayed

Int J Womens Health· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer.
Bader Alshamsan, Aisha Alshibany, Mahmoud A Elshenawy, Ahmed Badran, Tusneem Elhassan, Adher Alsayed

Cancer Manag Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer.
Hazem Ghebeh, Adher Al-Sayed, Riham Eiada, Leilani Cabangon, Dahish Ajarim

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Institute Review of HER-2/Neu-Positive Invasive Lobular Breast Carcinoma in an Arab Population.
Asif Husain Osmani, Asma M Tulbah, Adher AlSayed, Ali AlShanqeeti, Taher Al-Twegieri

Am J Case Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs.
Kausar Suleman, Ali Hassan Mushtaq, Emaan Haque, Ahmed Ali Badran, Dahish Ajarim, Adher Alsayed

Breast Care (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?
Kausar Suleman, Osama Almalik, Emaan Haque, Ali Mushtaq, Ahmed Badran, Adher Alsayed

Oncology· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects.
Huda H Al-Khalaf, Bothaina Al-Harbi, Adher Al-Sayed, Maria Arafah, Asma Tulbah

Mol Cell Biol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity and p16 Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity.
Huda H Al-Khalaf, Mrad Amir, Falah Al-Mohanna, Asma Tulbah, Adher Al-Sayed

Mol Cell Biol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "Letter to the Editor Concerning the Article-Impact of Surgery on Survival in Stage IV Breast Cancer".
Badria Al Johani, Osama Al Malik, Ehab Anwar, Asma Tulbah, Mohamed Alshabanah, Adher AlSayed

Breast J· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards safety of oral anti-cancer agents, the need to educate our pharmacists.
Sanaa Saeed Mekdad, Adher Dhaya AlSayed

Saudi Pharm J· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin-docetaxel with or without trastuzumab in locally advanced breast cancer.
Taher A L-Tweigeri, Adher AlSayed, Shafika Alawadi, Mohamed Ibrahim, Wafaa Ashour

Cancer Chemother Pharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the usefulness of a D dimer test in combination with clinical pretest probability score in the prediction and exclusion of Venous Thromboembolism by medical residents.
Tarek Owaidah, Nahlah AlGhasham, Saad AlGhamdi, Dania AlKhafaji, Bandar ALAmro, Adher AlSayed

Thromb J· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer.
Taher A Al-Tweigeri, Dahish S Ajarim, Adher A Alsayed, Mohamed M Rahal, Mohamed O Alshabanah

Med Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients.
Ameera Gaafar, Mahmoud Deeb Aljurf, Abdullah Al-Sulaiman, Alia Iqniebi, Pulicat S Manogaran

Exp Hematol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience.
Naser Elkum, Said Dermime, Dahish Ajarim, Ali Al-Zahrani, Adher Alsayed

BMC Cancer· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis